Implant decontamination during surgical peri‐implantitis treatment: a randomized, double‐blind, placebo‐controlled trial

Abstract

Implant surface decontamination with 0.12% CHX + 0.05% CPC in resective surgical treatment of peri-implantitis leads to a greater immediate suppression of anaerobic bacteria on the implant surface than a placebo-solution, but does not lead to superior clinical results. The long-term microbiological effect remains unknown.